drugset / Trial / NCT04705415

A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers

NCT04705415

Phase 1 Completed 54 enrolled NeuroBo Pharmaceuticals Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

A single and multiple ascending dose study of ANA001 in healthy adults to assess the safety and pharmacokinetics

Timeline

Start
2020-11-17
Primary completion
2021-10-13
Completion
2022-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Niclosamide Unknown 1000 mg Oral
Subject Niclosamide Unknown 2000 mg Oral
Subject Niclosamide Unknown 3000 mg Oral

Indications

No indication recorded.